Venus Medtech (02500.HK): Signs Term Sheet with Intended Investors for Proposed Financing of Up to RMB 500 Million

NewTimeSpace News: On July 2, 2026, Venus Medtech (02500.HK) announced that it has entered into an investment term sheet with Hangzhou Hi-Tech Group and Hangzhou Yingzhiqin. The intended investors intend to make an investment through subscribing for new shares and new convertible bonds, with a maximum total investment value of RMB 500 million and a deposit of RMB 100 million.

Both the subscription price per share and conversion price shall not exceed HK$2.5. Formal documentation is expected to be signed no later than August 31. The first closing (RMB 350 million) shall be completed within 30 working days upon shareholders’approval, while the second closing (RMB 150 million) shall be fulfilled within one year.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.